Caricamento...
Optimal Treatment Regimens for 5′‐Deoxy‐5‐fluorouridine, with or without (E)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine, against Various Tumors in Mice
The antitumor activity of 5′‐deoxy‐5‐fluorouridine (DFUR), a prodrug of 5‐fluorouracil (5‐FU), is markedly enhanced if DFUR treatment is combined with (E)‐5‐(2‐bromovinyl)‐2′‐deoxyuridine (BVDU). Combined oral administration of DFUR (10 mg/kg) and BVDU (10 mg/kg) three times (every 3 h) per day for...
Salvato in:
| Pubblicato in: | Jpn J Cancer Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Ltd
1990
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5918056/ https://ncbi.nlm.nih.gov/pubmed/2142152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb02586.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|